Form 4 for NNVC NANOVIRICIDES, INC.
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-08 · accession 0001140361-22-029132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-10 | 2022-08-08 | NNVC | Diwan Anil | Pres, Dir | G - Gift | $0.00 | -94.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2022-08-08 | G | D | 94,471 | $0.00 | 0 | D | — | — | (F2) Does not include 6,074 shares of Series A Convertible Preferred Stock (the "Series A Stock") owned by the reporting person which is convertible into three and one-half shares of common stock upon limited conditions. (F3) Does not include 200,000 shares of Series A Stock or 470,959 shares of common stock owned by TheraCour Pharma, Inc., over which the reporting person holds voting and dispositive power. |